RxDoctor Payments DataLook up a doctor →

Joel Michalski, MD

Internal Medicine · Omaha, NENPI 1437599248

Payments from drug & device makers

$1,634,920in general payments, 2019–2025

Across 318 payments — averaging $5141.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exelixis Inc.$572K
  • Pfizer$254K
  • Genmab A/s$246K
  • AbbVie$160K
  • Merck$149K
  • Amgen$119K
  • plus $135K from 37 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Exelixis Inc.95$571,929
Pfizer65$253,803
Genmab A/s60$246,041
AbbVie8$160,226
Merck4$149,139
Amgen5$118,837
AstraZeneca(2 entities)8$59,266
Astrazeneca UK Limited2$38,000
Mirati Therapeutics, Inc.8$31,482
Gilead(2 entities)7$3,763
Genentech USA, Inc.7$1,146
Sanofi US Services Inc.1$125
AVEO Pharmaceuticals, Inc.3$110
Hologic Sales And Service, LLC1$96
Genmab U.S., Inc.2$92
Daiichi Sankyo Inc.4$80
Siemens Medical Solutions USA, Inc.2$67
Pharmacyclics LLC, An Abbvie Company1$65
Novartis3$64
E.r. Squibb & Sons, L.L.C.3$63
Regeneron Healthcare Solutions, Inc.2$51
Takeda Pharmaceuticals U.S.A., Inc.2$47
Servier Pharmaceuticals LLC2$36
Blueprint Medicines Corporation1$32
Ipsen Biopharmaceuticals, Inc2$31
Adaptive Biotechnologies Corporation2$29
Array Biopharma Inc2$27
Syndax Pharmaceuticals, Inc.1$23
Sanofi1$22
Beone Medicines USA, Inc.1$22
Fennec Pharmaceuticals, Inc.1$22
Johnson & Johnson1$20
Bristol Myers Squibb1$18
Tersera Therapeutics LLC1$17
Eisai Inc.1$16
CTI Biopharma Corp.1$16
Octapharma USA, Inc.1$16
Pharmaessentia USA Corporation1$16
Sobi, Inc1$15
Stemline Therapeutics Inc.1$15
Coherus Oncology, Inc.1$15
Acrotech Biopharma Inc.1$12
Epizyme, Inc.1$12

How this compares

$1,634,920 in reported general payments places this provider in the 95th percentile of 570 internal medicine providers in Nebraska.

See all internal medicine providers in Nebraska →

Medicare billing

Part B allowed, 2024
$3,783,412
Medicare patients
709
Services billed
176,175

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Omaha

See the full list for Nebraska →

Where these figures come from

Is this you, or does something look wrong? →